Bacterial pathogens trigger specialized virulence factor secretion systems on encountering host cells. The ESX-1 protein secretion system of Mycobacterium tuberculosis-the causative agent of the human disease tuberculosis-delivers bacterial proteins into host cells during infection and is critical for virulence, but how it is regulated is unknown. Here we show that EspR (also known as Rv3849) is a key regulator of ESX-1 that is required for secretion and virulence in mice. EspR activates transcription of an operon that includes three ESX-1 components, Rv3616c-Rv3614c, whose expression in turn promotes secretion of ESX-1 substrates. EspR directly binds to and activates the Rv3616c-Rv3614c promoter and, unexpectedly, is itself secreted from the bacterial cell by the ESX-1 system that it regulates. Efflux of the DNA-binding regulator results in reduced Rv3616c-Rv3614c transcription, and thus reduced ESX-1 secretion. Our results reveal a direct negative feedback loop that regulates the activity of a secretion system essential for virulence. As the virulence factors secreted by the ESX-1 system are highly antigenic, fine control of secretion may be critical to successful infection.
Pathogenic microbes sense their environment and change their physiology to interact with the host. Mycobacterium tuberculosis, a pathogen of global importance, utilizes the ESX-1 protein secretion system to export virulence factors that disarm host macrophages [1] [2] [3] . ESX-1, also termed type VII secretion, is critical for virulence, and transports proteins from inside the bacterium across the cell envelope 1,2,4,5 . The entire ESX-1 system has been implicated in innate immune modulation, especially early after infection in macrophages 1, [6] [7] [8] . Consistent with this view, ESX-1 mutants are specifically defective in the early stages of growth in mice 1, 2, 5 . However, the role of the major secreted substrates, ESAT-6 and CFP-10, in virulence is a matter of current debate 2, 3, 9, 10 . Furthermore, these proteins are also potent antigens that elicit protection against tuberculosis in animal models, and are important components of vaccines currently in clinical trials [11] [12] [13] [14] [15] . The core machinery of the ESX-1 pathway, as well as ESAT-6 and CFP-10, are encoded at the genomic locus known as region of difference 1 (RD1), which is absent in the BCG vaccine strain 16 . Many other proteins encoded at the RD1 locus are also required for ESX-1 function, suggesting that this secretion apparatus is complex [17] [18] [19] . In addition to RD1-encoded genes, a separate locus required for ESX-1 system function has also been identified 20, 21 . This locus contains the genes Rv3616c-Rv3614c that are required for ESX-1 system activity; the Rv3616c protein, termed EspA, is a secreted substrate of the pathway 20, 21 . The discovery of this additional substrate also revealed the surprising phenomenon of mutually dependent export, in which the secretion of each substrate relies upon the secretion of the other substrates 20 . Although the mechanism underlying this co-dependence is not understood, it raises the possibility that substrates exert control over the secretion activity of the entire ESX-1 pathway. The phenomenon of mutually dependent secretion has complicated the genetic dissection of effector functions of single ESX-1 substrates, and the specific functions of the known ESX-1 substrates remain unclear.
In this work, we have identified a novel secreted substrate of the ESX-1 pathway, EspR. Surprisingly, this protein is a DNA-binding transcription factor that regulates M. tuberculosis genes that are required for ESX-1. The finding of a secreted DNA-binding protein reveals a novel homeostatic feedback mechanism by which the activity of a secretion system is monitored and regulated through coupling between secretion and transcription.
EspR (Rv3849) is secreted by ESX-1
In a genetic screen, we identified an M. tuberculosis transposon mutant that induced high levels of IL-12 from macrophages, a common phenotype of ESX-1 secretion mutants 1 , and determined that the transposable element inserted 13 nucleotides upstream of the gene Rv3849. Immunoblotting proteins from bacterial pellets and culture supernatants demonstrated that Rv3849 was secreted from wild-type cells, and although protein levels were severely reduced in the Rv3849 2 mutant, a low level of Rv3849 was still present in cell lysates (Fig. 1a, lanes 1-4) . Notably, ESAT-6 secretion was severely diminished in the Rv3849 2 mutant, with the block nearly equivalent to that of a mutant lacking the putative pore protein Rv3877 (Fig. 1a, lanes 1-4, 7 and 8 ). This defect was corrected upon integration of a single copy of the Rv3849 gene into mutant bacteria (Fig. 1a, lanes 5 and 6) . Importantly, Rv3849 secretion is blocked in bacteria lacking either Rv3877 (lanes 7 and 8) or ESAT-6 (encoded by esxA, lanes 9 and 10). Like other ESX-1 secretion mutants 1 
, Rv3849
2 mutant cells exhibited a characteristic growth defect during infection of mice (Fig. 1b) . Mutant bacteria grew poorly in the lungs during the first five days post-infection but this was followed by a period in which the viable mutants recovered normal growth kinetics. Although the mutant cells established a stable infection by three weeks, the bacterial burden was approximately an order of magnitude less than the wild type (Fig. 1b) . Therefore, Rv3849 is a new ESX-1 substrate that, like ESAT-6, CFP-10 and EspA, is required for the function of the entire ESX-1 system 20 
.
EspR is required for ESX-1 gene expression Although standard homology and motif searches failed to identify any putative functional domains in Rv3849, a secondary structure-based homology search 22 identified a significant match to the Bacillus subtilis transcription factor SinR, a helix-turn-helix (HTH) DNA-binding protein 23 . Modelling the three-dimensional structure of Rv3849 using the crystal structure of SinR as a template revealed considerable similarity between the two proteins, especially at the amino-terminal HTH domain (Fig. 1c) . Thus, although Rv3849 is an ESX-1 secreted protein, it bears striking similarities to a DNA-binding protein.
To determine if Rv3849 is a transcriptional regulator, we used M. tuberculosis microarrays to compare the global transcriptional profile between wild-type and Rv3849 2 bacteria grown in culture. Of the 4,505 genes represented on the array, expression of only five operons, representing 14 genes, was altered in Rv3849 2 mutant cells (Fig. 1d,  Supplementary Table 1 ). Three operons were activated in the Rv3849 2 mutant, including a putative operon containing the genes MT2035, Rv1982c and nrdF1 (Fig. 1d) . Notably, the Rv3616c-Rv3612c operon was one of two operons that were significantly downregulated in the Rv3849 2 mutant (Fig. 1d) . Quantitative RT-PCR (qPCR) to measure nrdF1 and Rv3615c messenger RNA levels provided additional support for the microarray data ( Supplementary Fig. 1 ). Because our Rv3849 mutant contains a transposon insertion in the promoter but retains an intact open reading frame, we made a deletion mutant in which the entire Rv3849 gene was replaced by allelic exchange. Importantly, the secretion and transcriptional phenotypes of the transposon mutant are indistinguishable from those of the deletion mutant ( Supplementary  Fig. 2 ). Because the genes Rv3616c, Rv3615c and Rv3614c are required for ESX-1, this result provided a direct link between Rv3849 and the secretion system. Overall, depletion of Rv3849 led to both positive and negative effects on the expression of a small number of M. tuberculosis genes, including one locus critical for ESX-1 function. Given the regulatory function of Rv3849 in ESX-1 secretion, we renamed this protein EspR (ESX-1 secreted protein regulator).
As ESX-1 functions early during infection 1, 8 , we reasoned that EspR may activate ESX-1 secretion upon phagocytosis by macrophages. To assay EspR activity, we measured transcription of the Rv3616c-Rv3612c operon during infection by qPCR. Rv3616c-Rv3612c expression was significantly induced by two hours postinfection in wild-type bacteria (Fig. 1e) , consistent with the recent finding that this operon is among a set of genes activated upon phagosomal acidification 24 . In espR 2 bacteria, however, Rv3616c-Rv3612c mRNA levels were near background two hours after infection, and although some induction occurred by four hours, the levels were much reduced compared to wild-type M. tuberculosis (Fig. 1e) . These data suggest that EspR is induced upon phagocytosis, activating expression of downstream ESX-1 components.
EspR binds DNA and activates transcription
To determine if EspR directly regulates Rv3616c-Rv3612c, we measured the activity of an Rv3616c promoter-lacZ transcriptional reporter in Mycobacterium smegmatis, a non-pathogenic relative of M. tuberculosis that lacks the Rv3616c-Rv3612c operon but encodes a homologue of EspR. The 680-base-pair (680-bp) promoter induced slight lacZ expression compared to the promoter-less construct, but was strongly activated by expression of M. tuberculosis EspR (Fig. 2a) . Deletions from the 59 end of the promoter indicated that sequences between 427 and 520 bp upstream of Rv3616c were required for EspR activity (Fig. 2a) . In electrophoretic mobility shift assays (EMSA), purified EspR, expressed as an N-terminal fusion with maltose binding protein (MBP-EspR), bound directly to probes that included at least 520 bp of the Rv3616c promoter (Fig. 2b) . The 427-bp probe was weakly bound by the fusion protein (Fig. 2b) , and no binding was detectable with a 320-bp probe (data not shown). Thus, EspR binds directly to the Rv3616c promoter and activates transcription. , and esxA 2 bacteria were probed for Rv3849, ESAT-6 and GroEL by western blot. GroEL, an intracellular protein used as a lysis control, was detected in cell pellets of all strains and was absent from supernatants. b, C57BL/6 mice were infected with 1 3 10 6 colony-forming units (c.f.u.) of wild-type and Rv3849 2 mutant M. tuberculosis through the intravenous route. Bacterial growth was monitored by counting c.f.u. from lung homogenates, and values at each time point were normalized to the initial dose at 24 h post-infection. For each bacterial strain, mean 6 s.d. is shown from five mice at each time point. *P , 0.05 between Rv3849 2 and wild-type. c, The crystal structure of SinR (violet) was used as a template to generate a structural model of Rv3849 (silver) using the program Modeller. 
To test this, we attempted to generate EspR mutants that specifically blocked either its transcriptional activity or its secretion. To this end we made point mutations in the N-terminal DNA-binding region of EspR in residues conserved among EspR homologues in related actinomycetes (Fig. 2c, top) . Each of these mutated proteins failed to bind the Rv3616c-Rv3612c promoter (Supplementary Fig. 3 ) and was unable to restore ESAT-6 secretion in espR 2 mutant M. tuberculosis (Fig. 2d, top) . Likewise, since the ESX-1 secretion signal in CFP-10 resides in the carboxy terminus 25 , we attempted to interrupt EspR secretion by creating a series of C-terminal truncation mutants (Fig. 2c, bottom) . Each of these mutants retained full DNA-binding activity, though with variable migration of the bound probe, suggesting alterations in the physical geometry of the protein-DNA complex ( Supplementary  Fig. 3 ). Deletion of 10 or more amino acids from the C terminus of EspR led to complete inactivation of ESX-1, while deletion of just the last five amino acids did not prevent ESAT-6 secretion (Fig. 2d, bottom) . Each of the variants was expressed at levels equivalent to that of the wild-type protein (data not shown). Gene expression analysis of two N-terminal and two C-terminal mutant-expressing strains showed that the ability of each mutant to restore ESX-1 secretion correlated with transcriptional control of the EspR regulon (Fig. 2e) . Point mutants that failed to bind DNA did not restore wild-type expression of EspR transcriptional targets to espR 2 bacteria (Fig. 2e,   lanes 4 and 5) . Likewise, EspR lacking five C-terminal amino acids retained partial transcriptional activity, whereas deletion of ten amino acids completely abrogated EspR activity (Fig. 2e, lanes 6  and 7 ). These data demonstrate that both the DNA-binding and C-terminal domains of EspR are required for transcriptional activity and for ESX-1 function.
Ectopic expression of Rv3616c-Rv3614c bypasses EspR
To determine if EspR plays an obligate role in ESX-1 function in addition to its transcriptional activity, we sought to bypass EspR by ectopic expression of the Rv3616c-Rv3612c operon in the espR 2 mutant. If the sole function of EspR in ESX-1 secretion is to activate this single operon, then ESX-1 secretion should be active under these conditions despite the lack of EspR. Because we had shown previously that Rv3613c and Rv3612c were not required for ESX-1 (ref. 21) , we expressed just Rv3616c-Rv3614c under the control of the constitutive GroEL promoter in espR 2 bacteria. In this strain, ESX-1 secretion was restored to levels similar to that of wild-type (Fig. 3a, lanes 7 and 8) , demonstrating that the sole requisite function of EspR in ESX-1 secretion is the transcriptional activation of Rv3616c-Rv3614c. This clearly excludes a role for EspR in subsequent secretory activities, distinguishing it from other co-dependent ESX-1 substrates.
Blocking EspR secretion potentiates ESX-1 gene transcription
As the secretion of EspR is not required for ESX-1 system function, the simplest model is that EspR secretion reduces its activity by 
P S P S P S P S P S P S P S P S P S P S P S P S P S P S P S decreasing the intracellular concentration of the activator. This model predicts that impairment of EspR secretion should result in increased intracellular EspR and resultant increases and decreases in the expression of its positive and negative transcriptional targets, respectively. Although we were unable to isolate a mutant EspR that was specifically impaired for secretion, we serendipitously found that addition of an N-terminal 33Flag epitope tag to EspR blocked its secretion (Fig. 3b) . Using antibodies that recognize EspR, Flag-EspR was detected exclusively in cell pellets, whereas the residual EspR expressed from the mutated chromosomal gene was effectively secreted (Fig. 3b, lanes 3 and 4) . Notably, the Flag epitope had little effect on DNA binding to the Rv3616c-Rv3612c promoter ( Supplementary Fig. 4) . Importantly, blocking EspR secretion increased EspR activity: genes activated by EspR were more highly expressed and negatively regulated genes were even further repressed (Fig. 3c) . Likewise, titration of intracellular EspR levels using a conditional promoter system led to corresponding increases in Rv3615c expression, showing that EspR activity can be modulated by its intracellular concentration (Fig. 3d, e and Supplementary Fig. 5 ). This result is consistent with the model that secretion of EspR functions to limit its intracellular activity, functionally coupling transcription and secretion in the ESX-1 system.
Discussion
We have discovered a simple transcriptional feedback mechanism by which secretion of the DNA-binding transcription factor EspR via the ESX-1 pathway negatively regulates this virulence factor secretion system. Secretion of transcriptional regulators is extremely rare in biology, with only three other examples in prokaryotes [26] [27] [28] [29] , none of which bind directly to DNA. In eukaryotes, HIV Tat 30 and members of the homeobox family 31 may be secreted, although the functional importance of their export is unclear. Our data are consistent with the model depicted in Fig. 4 , in which the flux of protein secretion through ESX-1 cycles between low-and high-activity states driven by the EspR-regulated activation of Rv3616c-Rv3612c and inhibited by secretion of the regulator.
In M. tuberculosis, tight control of the ESX-1 system during infection may be achieved through integration of multiple regulators, including both EspR and the two-component regulator PhoP (refs 32, 33) . Appropriate activity and timing of ESX-1 secretion is probably critical for survival, as this system is both an essential virulence determinant as well as a major source of potent immunostimulatory antigens. Given the early virulence role of ESX-1 secretion and the antigenicity of ESX-1 substrates to the adaptive immune response, it a, Rv3616c-Rv3614c were expressed in espR 2 bacteria under the control of the constitutive GroEL promoter. ESAT-6 and GroEL were analysed by western blot in cell pellets (P) and culture supernatants (S) of wild-type bacteria, espR 2 bacteria, complemented espR 2 bacteria, and espR 2 bacteria constitutively expressing Rv3616c-Rv3614c. b, Cell pellets (P) and culture supernatants (S) of wild-type bacteria and espR 2 bacteria expressing N-terminally Flag-tagged EspR were probed by western blot for EspR and GroEL. Arrows indicate endogenous EspR and 33-Flag-EspR. c, Microarray analysis comparing expression of EspR regulon genes in the strains used in b. Black, no change; yellow, increased expression; blue, decreased expression relative to wild-type; grey, missing data. Two replicate experiments are shown. d, e, EspR was placed under the transcriptional control of the Tetinducible promoter and introduced on an integrating plasmid into wild-type (WT) and DespR (DR) bacteria. Total RNA was harvested from mid-log phase M. tuberculosis grown in the presence of the indicated concentration of anhydrous tetracycline (ATC). Rv3615c (d) and espR (e) expression were measured by quantitative real-time PCR and normalized to 16S rRNA expression. Shown are mean 1 s.d. of triplicate measurements from one representative experiment of three. is intriguing to speculate that M. tuberculosis may balance the costs and benefits of ESX-1 activity by inducing secretion immediately after phagocytosis infection, through EspR, and then inactivating it as the infection progresses via secretion of the activator. Notably, it has been shown 34 that the number of ESAT-6 reactive T cells waned during chronic M. tuberculosis infection, a finding consistent with this idea. Understanding how key virulence factors and antigens are regulated during infection deepens our understanding of tuberculosis pathogenesis, and may affect the design of new vaccine strains with enhanced immunogenicity.
METHODS SUMMARY
All strains and plasmids used in this study are described in Supplementary Table  2 . Mouse infections, bacterial protein preparation and analysis, RNA preparation, and microarray hybridization were performed as previously described 1, 21, 35, 36 . EMSAs were performed by incubating purified protein with approximately 10 5 c.p.m. of radiolabelled probe in the presence of excess unlabelled non-specific DNA before running on a non-denaturing 6% polyacrylamide gel. For qPCR, M. tuberculosis cells were isolated from bone-marrowderived macrophages, total bacterial RNA was isolated and amplified using a Bacterial Amplification Kit (Ambion), reverse transcribed and used as template for PCR in the presence of SYBR Green. Oligonucleotides used for gene amplification are indicated in the Supplementary Methods and expression of individual mRNAs was normalized to expression of 16S rRNA.
Rv3849 was modelled using the program Modeller (http://salilab.org/modeller/) with the crystal structure of SinR as a template (PDB: 1B0N). The Rv3849 model was viewed and manipulated using the program Chimera (http:// www.cgl.ucsf.edu/chimera/).
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
